AnHeart Announces Upcoming Presentation of Preliminary Results from Phase II Trial of Taletrectinib in ROS1+ NSCLC at the ASCO 2021 Virtual Meeting

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice